Skip to content
DraconiticResearch
Search Sources API
190,839 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

2 Preclinical modeling of human glioblastoma immunotherapy resistance using a STING pathway defective mouse model

  1. 12UT Health Science Center Houston, Houston, TX, USA
  2. 21Dana-Farber Cancer Institute, Boston, MA, USA
  3. 3Dana-Farber Cancer Institute, Boston, MA, USA

Related

  1. Single-cell RNA sequencing combined with artificial intelligence to uncover immunotherapy biomarkers and decipher drug resistance mechanisms in glioblastoma.
    Tao Fu, Mengwan Hu, Xian Wu
    Frontiers in oncologyPeer-reviewedCC BYFull textHuman geneticsEurope PMCCrossref
  2. Combined HDAC and ATM inhibition with radiation in preclinical glioblastoma models
    S. Qualls-Histed, K. Chung, G. Uzunalli +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. An Orthotopic Xenograft Model for Preclinical Evaluation of CAR T Cell Therapy in Glioblastoma.
    Julian Hübner, Rhonda McFleder, Chi Wang Ip +4
    Current protocolsPeer-reviewedCC BYFull textHuman geneticsEurope PMCPMC
  4. Advanced machine learning strategies for predicting therapy response in preclinical glioblastoma using longitudinal MRI
    Javier González, Ana Paula Candiota, Alfredo Vellido
    Scientific ReportsPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossref
  5. Spatial heterogeneity in glioblastoma: linking single-cell and spatial multi-omics to vaccine immunotherapy
    Juan Yuan, Yong Liu
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textHuman geneticsPMCCrossrefEurope PMC
BibTeX
@article{chaudhri2026preclinical,
  title = {{2 Preclinical modeling of human glioblastoma immunotherapy resistance using a STING pathway defective mouse model}},
  author = {Apoorvi Chaudhri and Ping Hua and Gordon J Freeman and Prafulla C Gokhale and Benajmin Eschle and Maia S Lineberry and David A Reardon},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0002},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0002},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 2 Preclinical modeling of human glioblastoma immunotherapy resistance using a STING pathway defective mouse model
AU  - Apoorvi Chaudhri
AU  - Ping Hua
AU  - Gordon J Freeman
AU  - Prafulla C Gokhale
AU  - Benajmin Eschle
AU  - Maia S Lineberry
AU  - David A Reardon
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0002
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0002
SN  - 2051-1426
ER  -